<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2017-05-10" version="230">
<accession>P11362</accession>
<accession>A8K6T9</accession>
<accession>A8K8V5</accession>
<accession>C1KBH8</accession>
<accession>P17049</accession>
<accession>Q02063</accession>
<accession>Q02065</accession>
<accession>Q14306</accession>
<accession>Q14307</accession>
<accession>Q53H63</accession>
<accession>Q59H40</accession>
<accession>Q5BJG2</accession>
<accession>Q8N685</accession>
<accession>Q9UD50</accession>
<accession>Q9UDF0</accession>
<accession>Q9UDF1</accession>
<accession>Q9UDF2</accession>
<name>FGFR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Fibroblast growth factor receptor 1</fullName>
<shortName>FGFR-1</shortName>
<ecNumber evidence="26 30 55 56 58 62 77">2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Basic fibroblast growth factor receptor 1</fullName>
<shortName>BFGFR</shortName>
<shortName>bFGF-R-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Fms-like tyrosine kinase 2</fullName>
<shortName>FLT-2</shortName>
</alternativeName>
<alternativeName>
<fullName>N-sam</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Fgr</fullName>
</alternativeName>
<cdAntigenName>CD331</cdAntigenName>
</protein>
<gene>
<name type="primary">FGFR1</name>
<name type="synonym">BFGFR</name>
<name type="synonym">CEK</name>
<name type="synonym">FGFBR</name>
<name type="synonym">FLG</name>
<name type="synonym">FLT2</name>
<name type="synonym">HBGFR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="169" first="680" last="685">
<title>The complete amino acid sequence of the shorter form of human basic fibroblast growth factor receptor deduced from its cDNA.</title>
<authorList>
<person name="Itoh N."/>
<person name="Terachi T."/>
<person name="Ohta M."/>
<person name="Seo M.K."/>
</authorList>
<dbReference type="PubMed" id="2162671"/>
<dbReference type="DOI" id="10.1016/0006-291X(90)90384-Y"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 15)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="EMBO J." volume="9" first="2685" last="2692">
<title>Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors.</title>
<authorList>
<person name="Dionne C.A."/>
<person name="Crumley G.R."/>
<person name="Bellot F."/>
<person name="Kaplow J.M."/>
<person name="Searfoss G."/>
<person name="Ruta M."/>
<person name="Burgess W.H."/>
<person name="Jaye M."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="1697263"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH FGF1 AND FGF2</scope>
<source>
<tissue>Neonatal brain stem</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="Mol. Cell. Biol." volume="10" first="4728" last="4736">
<title>Diverse forms of a receptor for acidic and basic fibroblast growth factors.</title>
<authorList>
<person name="Johnson D.E."/>
<person name="Lee P.L."/>
<person name="Lu J."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="2167437"/>
<dbReference type="DOI" id="10.1128/MCB.10.9.4728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; 15; 17 AND 18)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="1906" last="1906">
<title>Complete sequence of a human receptor for acidic and basic fibroblast growth factors.</title>
<authorList>
<person name="Isacchi A."/>
<person name="Bergonzoni L."/>
<person name="Sarmientos P."/>
</authorList>
<dbReference type="PubMed" id="2159626"/>
<dbReference type="DOI" id="10.1093/nar/18.7.1906"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1991" name="Growth Factors" volume="4" first="197" last="208">
<title>cDNA cloning and expression of a human FGF receptor which binds acidic and basic FGF.</title>
<authorList>
<person name="Wennstroem S."/>
<person name="Sandstroem C."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="1722683"/>
<dbReference type="DOI" id="10.3109/08977199109104816"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 14)</scope>
<scope>INTERACTION WITH FGF1 AND FGF2</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1991" name="Growth Factors" volume="5" first="115" last="127">
<title>Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system.</title>
<authorList>
<person name="Kiefer M.C."/>
<person name="Baird A."/>
<person name="George-Nascimento C."/>
<person name="Nguyen T."/>
<person name="Mason O.B."/>
<person name="Boley L.J."/>
<person name="Valenzuela P."/>
<person name="Barr P.J."/>
</authorList>
<dbReference type="PubMed" id="1662973"/>
<dbReference type="DOI" id="10.3109/08977199109000276"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 14)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="1195" last="1202">
<title>Alternative splicing generates at least five different isoforms of the human basic-FGF receptor.</title>
<authorList>
<person name="Eisemann A."/>
<person name="Ahn J.A."/>
<person name="Graziani G."/>
<person name="Tronick S.R."/>
<person name="Ron D."/>
</authorList>
<dbReference type="PubMed" id="1650441"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 6; 14; 15 AND 16)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1991" name="Science" volume="251" first="665" last="668">
<title>Fibroblast growth factor receptors from liver vary in three structural domains.</title>
<authorList>
<person name="Hou J."/>
<person name="Kan M."/>
<person name="McKeehan K."/>
<person name="McBride G."/>
<person name="Adams P."/>
<person name="McKeehan W.L."/>
</authorList>
<dbReference type="PubMed" id="1846977"/>
<dbReference type="DOI" id="10.1126/science.1846977"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11; 12 AND 13)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Cancer Res." volume="52" first="3367" last="3371">
<title>K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.</title>
<authorList>
<person name="Hattori Y."/>
<person name="Odagiri H."/>
<person name="Katoh O."/>
<person name="Sakamoto H."/>
<person name="Morita T."/>
<person name="Shimotohno K."/>
<person name="Tobinai K."/>
<person name="Sugimura T."/>
<person name="Terada M."/>
</authorList>
<dbReference type="PubMed" id="1317750"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Hum. Reprod." volume="25" first="1076" last="1080">
<title>A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1.</title>
<authorList>
<person name="Miura K."/>
<person name="Miura S."/>
<person name="Yoshiura K."/>
<person name="Seminara S."/>
<person name="Hamaguchi D."/>
<person name="Niikawa N."/>
<person name="Masuzaki H."/>
</authorList>
<dbReference type="PubMed" id="20139426"/>
<dbReference type="DOI" id="10.1093/humrep/deq006"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 19)</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6; 14 AND 21)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="12">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 14 AND 20)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="13">
<citation type="submission" date="2004-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-22; ARG-818 AND CYS-822</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 14 AND 15)</scope>
<scope>VARIANT GLY-213</scope>
<source>
<tissue>Pancreas</tissue>
<tissue>Testis</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="Biochemistry" volume="33" first="10229" last="10248">
<title>Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.</title>
<authorList>
<person name="Pantoliano M.W."/>
<person name="Horlick R.A."/>
<person name="Springer B.A."/>
<person name="Van Dyk D.E."/>
<person name="Tobery T."/>
<person name="Wetmore D.R."/>
<person name="Lear J.D."/>
<person name="Nahapetian A.T."/>
<person name="Bradley J.D."/>
<person name="Sisk W.P."/>
</authorList>
<dbReference type="PubMed" id="7520751"/>
<dbReference type="DOI" id="10.1021/bi00200a003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-370 (ISOFORM 15)</scope>
<scope>PROTEIN SEQUENCE OF 22-129 (ISOFORM 15)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="203" first="450" last="458">
<title>Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.</title>
<authorList>
<person name="Rusnati M."/>
<person name="Coltrini D."/>
<person name="Caccia P."/>
<person name="Dell'Era P."/>
<person name="Zoppetti G."/>
<person name="Oreste P."/>
<person name="Valsasina B."/>
<person name="Presta M."/>
</authorList>
<dbReference type="PubMed" id="8074689"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.2203"/>
</citation>
<scope>PROTEIN SEQUENCE OF 81-100 (ISOFORMS 1/2/4/5/14/16)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1988" name="Oncogene" volume="3" first="9" last="15">
<title>A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation.</title>
<authorList>
<person name="Ruta M."/>
<person name="Howk R."/>
<person name="Ricca G."/>
<person name="Drohan W."/>
<person name="Zabelshansky M."/>
<person name="Laureys G."/>
<person name="Barton D.E."/>
<person name="Francke U."/>
<person name="Schlessinger J."/>
<person name="Givol D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 201-822 (ISOFORMS 1/6/10/14/15)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="4627" last="4634">
<title>The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain.</title>
<authorList>
<person name="Johnson D.E."/>
<person name="Lu J."/>
<person name="Chen H."/>
<person name="Werner S."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="1652059"/>
<dbReference type="DOI" id="10.1128/MCB.11.9.4627"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 313-391 (ISOFORMS 17/18)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 313-360 (ISOFORMS 1/2/4/5/6/7/8/9/10/11/12/13/14/15)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 313-360 (ISOFORM 19)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Foreskin fibroblast</tissue>
<tissue>Umbilical vein</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="1500" last="1507">
<title>A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.</title>
<authorList>
<person name="Gutkind S.J."/>
<person name="Link D.C."/>
<person name="Katamine S."/>
<person name="Lacal P."/>
<person name="Miki T."/>
<person name="Ley T.J."/>
<person name="Robbins K.C."/>
</authorList>
<dbReference type="PubMed" id="1847500"/>
<dbReference type="DOI" id="10.1128/MCB.11.3.1500"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="5068" last="5078">
<title>A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.</title>
<authorList>
<person name="Mohammadi M."/>
<person name="Honegger A.M."/>
<person name="Rotin D."/>
<person name="Fischer R."/>
<person name="Bellot F."/>
<person name="Li W."/>
<person name="Dionne C.A."/>
<person name="Jaye M."/>
<person name="Rubinstein M."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="1656221"/>
<dbReference type="DOI" id="10.1128/MCB.11.10.5068"/>
</citation>
<scope>INTERACTION WITH PLCG1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1992" name="Nature" volume="358" first="678" last="681">
<title>Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.</title>
<authorList>
<person name="Peters K.G."/>
<person name="Marie J."/>
<person name="Wilson E."/>
<person name="Ives H.E."/>
<person name="Escobedo J."/>
<person name="del Rosario M."/>
<person name="Mirda D."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="1379697"/>
<dbReference type="DOI" id="10.1038/358678a0"/>
</citation>
<scope>MUTAGENESIS OF TYR-766</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH PLCG1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1992" name="Nature" volume="358" first="681" last="684">
<title>Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.</title>
<authorList>
<person name="Mohammadi M."/>
<person name="Dionne C.A."/>
<person name="Li W."/>
<person name="Lin N."/>
<person name="Spivak T."/>
<person name="Honegger A.M."/>
<person name="Jaye M."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="1379698"/>
<dbReference type="DOI" id="10.1038/358681a0"/>
</citation>
<scope>MUTAGENESIS OF TYR-766</scope>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="17056" last="17061">
<title>Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766.</title>
<authorList>
<person name="Sorokin A."/>
<person name="Mohammadi M."/>
<person name="Huang J."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7516330"/>
</citation>
<scope>MUTAGENESIS OF TYR-766</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="977" last="989">
<title>Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction.</title>
<authorList>
<person name="Mohammadi M."/>
<person name="Dikic I."/>
<person name="Sorokin A."/>
<person name="Burgess W.H."/>
<person name="Jaye M."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="8622701"/>
<dbReference type="DOI" id="10.1128/MCB.16.3.977"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-463; TYR-583; TYR-585; TYR-653; TYR-654 AND TYR-730</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PLCG1 AND SHC1; ACTIVATION OF MAP KINASES AND REGULATION OF CELL PROLIFERATION AND DIFFERENTIATION</scope>
<scope>MUTAGENESIS OF TYR-653 AND TYR-654</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="15292" last="15297">
<title>Receptor specificity of the fibroblast growth factor family.</title>
<authorList>
<person name="Ornitz D.M."/>
<person name="Xu J."/>
<person name="Colvin J.S."/>
<person name="McEwen D.G."/>
<person name="MacArthur C.A."/>
<person name="Coulier F."/>
<person name="Gao G."/>
<person name="Goldfarb M."/>
</authorList>
<dbReference type="PubMed" id="8663044"/>
<dbReference type="DOI" id="10.1074/jbc.271.25.15292"/>
</citation>
<scope>INTERACTION WITH FGF1; FGF2; FGF4; FGF5; FGF6</scope>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1998" name="Blood" volume="92" first="1735" last="1742">
<title>Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.</title>
<authorList>
<person name="Reiter A."/>
<person name="Sohal J."/>
<person name="Kulkarni S."/>
<person name="Chase A."/>
<person name="Macdonald D.H.C."/>
<person name="Aguiar R.C.T."/>
<person name="Goncalves C."/>
<person name="Hernandez J.M."/>
<person name="Jennings B.A."/>
<person name="Goldman J.M."/>
<person name="Cross N.C.P."/>
</authorList>
<dbReference type="PubMed" id="9716603"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ZMYM2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="Nature" volume="393" first="812" last="817">
<title>Structure of a heparin-linked biologically active dimer of fibroblast growth factor.</title>
<authorList>
<person name="DiGabriele A.D."/>
<person name="Lax I."/>
<person name="Chen D.I."/>
<person name="Svahn C.M."/>
<person name="Jaye M."/>
<person name="Schlessinger J."/>
<person name="Hendrickson W.A."/>
</authorList>
<dbReference type="PubMed" id="9655399"/>
<dbReference type="DOI" id="10.1038/31741"/>
</citation>
<scope>INTERACTION WITH FGF1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="Blood" volume="93" first="1381" last="1389">
<title>The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.</title>
<authorList>
<person name="Popovici C."/>
<person name="Zhang B."/>
<person name="Gregoire M.-J."/>
<person name="Jonveaux P."/>
<person name="Lafage-Pochitaloff M."/>
<person name="Birnbaum D."/>
<person name="Pebusque M.-J."/>
</authorList>
<dbReference type="PubMed" id="9949182"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FGFR1OP</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="6217" last="6228">
<title>Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.</title>
<authorList>
<person name="Wang J."/>
<person name="Dai H."/>
<person name="Yousaf N."/>
<person name="Moussaif M."/>
<person name="Deng Y."/>
<person name="Boufelliga A."/>
<person name="Swamy O.R."/>
<person name="Leone M.E."/>
<person name="Riedel H."/>
</authorList>
<dbReference type="PubMed" id="10454568"/>
<dbReference type="DOI" id="10.1128/MCB.19.9.6217"/>
</citation>
<scope>INTERACTION WITH GRB10</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2000" name="Am. J. Med. Genet." volume="93" first="22" last="28">
<title>Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature.</title>
<authorList>
<person name="Roscioli T."/>
<person name="Flanagan S."/>
<person name="Kumar P."/>
<person name="Masel J."/>
<person name="Gattas M."/>
<person name="Hyland V.J."/>
<person name="Glass I.A."/>
</authorList>
<dbReference type="PubMed" id="10861678"/>
<dbReference type="DOI" id="10.1002/1096-8628(20000703)93:1&lt;22::AID-AJMG5>3.0.CO;2-U"/>
</citation>
<scope>INVOLVEMENT IN JWS</scope>
<scope>VARIANT JWS ARG-252</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="Blood" volume="95" first="1788" last="1796">
<title>FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).</title>
<authorList>
<person name="Guasch G."/>
<person name="Mack G.J."/>
<person name="Popovici C."/>
<person name="Dastugue N."/>
<person name="Birnbaum D."/>
<person name="Rattner J.B."/>
<person name="Pebusque M.-J."/>
</authorList>
<dbReference type="PubMed" id="10688839"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH CNTRL</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="6074" last="6079">
<title>Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.</title>
<authorList>
<person name="Ong S.H."/>
<person name="Hadari Y.R."/>
<person name="Gotoh N."/>
<person name="Guy G.R."/>
<person name="Schlessinger J."/>
<person name="Lax I."/>
</authorList>
<dbReference type="PubMed" id="11353842"/>
<dbReference type="DOI" id="10.1073/pnas.111114298"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF FRS2 AND GAB1 AND IN ACTIVATION OF PIK3R1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="2881" last="2893">
<title>The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.</title>
<authorList>
<person name="Cross M.J."/>
<person name="Lu L."/>
<person name="Magnusson P."/>
<person name="Nyqvist D."/>
<person name="Holmqvist K."/>
<person name="Welsh M."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="12181353"/>
<dbReference type="DOI" id="10.1091/mbc.E02-02-0103"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF SIGNALING VIA RAS AND MAP KINASES AND CELL PROLIFERATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FRS2; SHB AND PTPN11/SHP2</scope>
<scope>INTERACTION WITH SHB AND FGF2</scope>
<scope>MUTAGENESIS OF TYR-766</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Genes Chromosomes Cancer" volume="40" first="78" last="83">
<title>Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.</title>
<authorList>
<person name="Grand E.K."/>
<person name="Grand F.H."/>
<person name="Chase A.J."/>
<person name="Ross F.M."/>
<person name="Corcoran M.M."/>
<person name="Oscier D.G."/>
<person name="Cross N.C.P."/>
</authorList>
<dbReference type="PubMed" id="15034873"/>
<dbReference type="DOI" id="10.1002/gcc.20023"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FGFR1OP2</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="29325" last="29335">
<title>90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.</title>
<authorList>
<person name="Hu Y."/>
<person name="Fang X."/>
<person name="Dunham S.M."/>
<person name="Prada C."/>
<person name="Stachowiak E.K."/>
<person name="Stachowiak M.K."/>
</authorList>
<dbReference type="PubMed" id="15117958"/>
<dbReference type="DOI" id="10.1074/jbc.M311144200"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF RPS6KA1 AND CREB1</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH RPS6KA1</scope>
<scope>MUTAGENESIS OF LYS-514</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-296</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Blood" volume="108" first="4202" last="4204">
<title>Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.</title>
<authorList>
<person name="Gu T.-L."/>
<person name="Goss V.L."/>
<person name="Reeves C."/>
<person name="Popova L."/>
<person name="Nardone J."/>
<person name="Macneill J."/>
<person name="Walters D.K."/>
<person name="Wang Y."/>
<person name="Rush J."/>
<person name="Comb M.J."/>
<person name="Druker B.J."/>
<person name="Polakiewicz R.D."/>
</authorList>
<dbReference type="PubMed" id="16946300"/>
<dbReference type="DOI" id="10.1182/blood-2006-06-026666"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FGFR1OP2</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15694" last="15700">
<title>Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.</title>
<authorList>
<person name="Zhang X."/>
<person name="Ibrahimi O.A."/>
<person name="Olsen S.K."/>
<person name="Umemori H."/>
<person name="Mohammadi M."/>
<person name="Ornitz D.M."/>
</authorList>
<dbReference type="PubMed" id="16597617"/>
<dbReference type="DOI" id="10.1074/jbc.M601252200"/>
</citation>
<scope>INTERACTION WITH FGF1; FGF8; FGF10; FGF19; FGF21; FGF22 AND FGF23</scope>
<scope>FUNCTION IN STIMULATION OF CELL PROLIFERATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="2223" last="2235">
<title>Factors controlling fibroblast growth factor receptor-1's cytoplasmic trafficking and its regulation as revealed by FRAP analysis.</title>
<authorList>
<person name="Dunham-Ems S.M."/>
<person name="Pudavar H.E."/>
<person name="Myers J.M."/>
<person name="Maher P.A."/>
<person name="Prasad P.N."/>
<person name="Stachowiak M.K."/>
</authorList>
<dbReference type="PubMed" id="16481405"/>
<dbReference type="DOI" id="10.1091/mbc.E05-08-0749"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="711" last="717">
<title>Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction.</title>
<authorList>
<person name="Furdui C.M."/>
<person name="Lew E.D."/>
<person name="Schlessinger J."/>
<person name="Anderson K.S."/>
</authorList>
<dbReference type="PubMed" id="16507368"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.01.022"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-463; TYR-653; TYR-654; TYR-583 AND TYR-585</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="Blood" volume="110" first="360" last="369">
<title>14-3-3 integrates pro-survival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1 transformed hematopoietic cells.</title>
<authorList>
<person name="Dong S."/>
<person name="Kang S."/>
<person name="Gu T."/>
<person name="Kardar S."/>
<person name="Fu H."/>
<person name="Lonial S."/>
<person name="Khoury H.J."/>
<person name="Khuri F."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17389761"/>
<dbReference type="DOI" id="10.1182/blood-2006-12-065615"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FGFR1OP2</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="26687" last="26695">
<title>Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.</title>
<authorList>
<person name="Kurosu H."/>
<person name="Choi M."/>
<person name="Ogawa Y."/>
<person name="Dickson A.S."/>
<person name="Goetz R."/>
<person name="Eliseenkova A.V."/>
<person name="Mohammadi M."/>
<person name="Rosenblatt K.P."/>
<person name="Kliewer S.A."/>
<person name="Kuro-o M."/>
</authorList>
<dbReference type="PubMed" id="17623664"/>
<dbReference type="DOI" id="10.1074/jbc.M704165200"/>
</citation>
<scope>INTERACTION WITH FGF19; FGF21 AND KLB</scope>
<scope>FUNCTION IN REGULATION OF GLUCOSE UPTAKE IN ADIPOCYTES</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="212" first="148" last="156">
<title>Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus.</title>
<authorList>
<person name="Citores L."/>
<person name="Bai L."/>
<person name="Sorensen V."/>
<person name="Olsnes S."/>
</authorList>
<dbReference type="PubMed" id="17311277"/>
<dbReference type="DOI" id="10.1002/jcp.21014"/>
</citation>
<scope>FUNCTION IN STAT1 PHOSPHORYLATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="18066" last="18075">
<title>Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.</title>
<authorList>
<person name="Mori S."/>
<person name="Wu C.Y."/>
<person name="Yamaji S."/>
<person name="Saegusa J."/>
<person name="Shi B."/>
<person name="Ma Z."/>
<person name="Kuwabara Y."/>
<person name="Lam K.S."/>
<person name="Isseroff R.R."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="18441324"/>
<dbReference type="DOI" id="10.1074/jbc.M801213200"/>
</citation>
<scope>BINDING TO FGF1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH INTEGRIN AND FGF1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Mol. Biol. Cell" volume="19" first="3390" last="3403">
<title>Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.</title>
<authorList>
<person name="Haugsten E.M."/>
<person name="Malecki J."/>
<person name="Bjorklund S.M."/>
<person name="Olsnes S."/>
<person name="Wesche J."/>
</authorList>
<dbReference type="PubMed" id="18480409"/>
<dbReference type="DOI" id="10.1091/mbc.E07-12-1219"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION AS FGF1 RECEPTOR AND IN ACTIVATION OF PLCG1; FRS2; MAPK1/ERK2 AND MAPK3/ERK1</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="29905" last="29920">
<title>Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.</title>
<authorList>
<person name="Hu Y."/>
<person name="Guimond S.E."/>
<person name="Travers P."/>
<person name="Cadman S."/>
<person name="Hohenester E."/>
<person name="Turnbull J.E."/>
<person name="Kim S.H."/>
<person name="Bouloux P.M."/>
</authorList>
<dbReference type="PubMed" id="19696444"/>
<dbReference type="DOI" id="10.1074/jbc.M109.049155"/>
</citation>
<scope>INTERACTION WITH ANOS1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="2401" last="2412">
<title>Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control.</title>
<authorList>
<person name="Dunham-Ems S.M."/>
<person name="Lee Y.W."/>
<person name="Stachowiak E.K."/>
<person name="Pudavar H."/>
<person name="Claus P."/>
<person name="Prasad P.N."/>
<person name="Stachowiak M.K."/>
</authorList>
<dbReference type="PubMed" id="19261810"/>
<dbReference type="DOI" id="10.1091/mbc.E08-06-0600"/>
</citation>
<scope>FUNCTION IN CHROMATIN BINDING AND TRANSCRIPTION REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA6" last="RA6">
<title>The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations.</title>
<authorList>
<person name="Lew E.D."/>
<person name="Furdui C.M."/>
<person name="Anderson K.S."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="19224897"/>
<dbReference type="DOI" id="10.1126/scisignal.2000021"/>
</citation>
<scope>FUNCTION AS PROTO-ONCOGENE</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF ASP-623</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-463; TYR-653; TYR-654; TYR-583; TYR-585 AND TYR-730</scope>
<scope>CHARACTERIZATION OF VARIANT ECCL LYS-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E10273" last="E10273">
<title>A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.</title>
<authorList>
<person name="Yamaji S."/>
<person name="Saegusa J."/>
<person name="Ieguchi K."/>
<person name="Fujita M."/>
<person name="Mori S."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="20422052"/>
<dbReference type="DOI" id="10.1371/journal.pone.0010273"/>
</citation>
<scope>BINDING TO FGF1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH INTEGRIN AND FGF1</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="407" last="412">
<title>Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.</title>
<authorList>
<person name="Goetz R."/>
<person name="Nakada Y."/>
<person name="Hu M.C."/>
<person name="Kurosu H."/>
<person name="Wang L."/>
<person name="Nakatani T."/>
<person name="Shi M."/>
<person name="Eliseenkova A.V."/>
<person name="Razzaque M.S."/>
<person name="Moe O.W."/>
<person name="Kuro-o M."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="19966287"/>
<dbReference type="DOI" id="10.1073/pnas.0902006107"/>
</citation>
<scope>INTERACTION WITH FGF23 AND KLB</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2011" name="EMBO J." volume="30" first="3259" last="3273">
<title>Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function.</title>
<authorList>
<person name="Persaud A."/>
<person name="Alberts P."/>
<person name="Hayes M."/>
<person name="Guettler S."/>
<person name="Clarke I."/>
<person name="Sicheri F."/>
<person name="Dirks P."/>
<person name="Ciruna B."/>
<person name="Rotin D."/>
</authorList>
<dbReference type="PubMed" id="21765395"/>
<dbReference type="DOI" id="10.1038/emboj.2011.234"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF AKT1; PLCG1; MAPK1/ERK2</scope>
<scope>MAPK3/ERK1 AND MAP KINASE SIGNALING</scope>
<scope>FUNCTION IN REGULATION OF NEURONAL DIFFERENTIATION AND EMBRYONIC DEVELOPMENT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NEDD4; PLCG1 AND FRS2</scope>
<scope>UBIQUITINATION</scope>
<scope>DEGRADATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="Int. J. Dev. Biol." volume="46" first="393" last="400">
<title>The structure and function of vertebrate fibroblast growth factor receptor 1.</title>
<authorList>
<person name="Groth C."/>
<person name="Lardelli M."/>
</authorList>
<dbReference type="PubMed" id="12141425"/>
</citation>
<scope>REVIEW ON ALTERNATIVE SPLICE FORMS; LIGANDS; SIGNALING PATHWAYS AND SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2005" name="Cytokine Growth Factor Rev." volume="16" first="139" last="149">
<title>Cellular signaling by fibroblast growth factor receptors.</title>
<authorList>
<person name="Eswarakumar V.P."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="15863030"/>
<dbReference type="DOI" id="10.1016/j.cytogfr.2005.01.001"/>
</citation>
<scope>REVIEW ON FUNCTION; ROLE IN DISEASE; SIGNALING PATHWAYS; SUBUNIT; DOMAIN STRUCTURE; LIGAND SELECTIVITY AND ENZYME REGULATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2010" name="Nat. Rev. Cancer" volume="10" first="116" last="129">
<title>Fibroblast growth factor signalling: from development to cancer.</title>
<authorList>
<person name="Turner N."/>
<person name="Grose R."/>
</authorList>
<dbReference type="PubMed" id="20094046"/>
<dbReference type="DOI" id="10.1038/nrc2780"/>
</citation>
<scope>REVIEW ON FUNCTION IN FGF SIGNALING</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2010" name="Trends Endocrinol. Metab." volume="21" first="385" last="393">
<title>Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.</title>
<authorList>
<person name="Hu Y."/>
<person name="Bouloux P.M."/>
</authorList>
<dbReference type="PubMed" id="20117945"/>
<dbReference type="DOI" id="10.1016/j.tem.2010.01.004"/>
</citation>
<scope>REVIEW ON SIGNALING AND ROLE IN KALLMAN SYNDROME</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="98" first="579" last="587">
<title>Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis.</title>
<authorList>
<consortium name="University of Washington Center for Mendelian Genomics"/>
<consortium name="Care4Rare Canada Consortium"/>
<person name="Bennett J.T."/>
<person name="Tan T.Y."/>
<person name="Alcantara D."/>
<person name="Tetrault M."/>
<person name="Timms A.E."/>
<person name="Jensen D."/>
<person name="Collins S."/>
<person name="Nowaczyk M.J."/>
<person name="Lindhurst M.J."/>
<person name="Christensen K.M."/>
<person name="Braddock S.R."/>
<person name="Brandling-Bennett H."/>
<person name="Hennekam R.C."/>
<person name="Chung B."/>
<person name="Lehman A."/>
<person name="Su J."/>
<person name="Ng S."/>
<person name="Amor D.J."/>
<person name="Majewski J."/>
<person name="Biesecker L.G."/>
<person name="Boycott K.M."/>
<person name="Dobyns W.B."/>
<person name="O'Driscoll M."/>
<person name="Moog U."/>
<person name="McDonell L.M."/>
</authorList>
<dbReference type="PubMed" id="26942290"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.02.006"/>
</citation>
<scope>INVOLVEMENT IN ECCL</scope>
<scope>VARIANTS ECCL LYS-546 AND GLU-656</scope>
<scope>VARIANT MET-561</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1996" name="Cell" volume="86" first="577" last="587">
<title>Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.</title>
<authorList>
<person name="Mohammadi M."/>
<person name="Schlessinger J."/>
<person name="Hubbard S.R."/>
</authorList>
<dbReference type="PubMed" id="8752212"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80131-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 464-762</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1997" name="Science" volume="276" first="955" last="960">
<title>Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.</title>
<authorList>
<person name="Mohammadi M."/>
<person name="McMahon G."/>
<person name="Sun L."/>
<person name="Tang C."/>
<person name="Hirth P."/>
<person name="Yeh B.K."/>
<person name="Hubbard S.R."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="9139660"/>
<dbReference type="DOI" id="10.1126/science.276.5314.955"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 464-762 IN COMPLEX WITH SU4984</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2000" name="Cell" volume="101" first="413" last="424">
<title>Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.</title>
<authorList>
<person name="Plotnikov A.N."/>
<person name="Hubbard S.R."/>
<person name="Schlessinger J."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="10830168"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80851-X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 141-365 IN COMPLEX WITH FGF1</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2000" name="Mol. Cell" volume="6" first="743" last="750">
<title>Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.</title>
<authorList>
<person name="Schlessinger J."/>
<person name="Plotnikov A.N."/>
<person name="Ibrahimi O.A."/>
<person name="Eliseenkova A.V."/>
<person name="Yeh B.K."/>
<person name="Yayon A."/>
<person name="Linhardt R.J."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="11030354"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)00073-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 143-364 IN COMPLEX WITH FGF2 AND HEPARIN</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="62">
<citation type="submission" date="2005-11" db="PDB data bank">
<title>Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 38-124</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="Cell" volume="138" first="514" last="524">
<title>The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site.</title>
<authorList>
<person name="Bae J.H."/>
<person name="Lew E.D."/>
<person name="Yuzawa S."/>
<person name="Tome F."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="19665973"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.028"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 458-774 IN COMPLEX WITH PLCG1 AND ATP ANALOG</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-653; TYR-654 AND TYR-766</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="2866" last="2871">
<title>Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells.</title>
<authorList>
<person name="Bae J.H."/>
<person name="Boggon T.J."/>
<person name="Tome F."/>
<person name="Mandiyan V."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="20133753"/>
<dbReference type="DOI" id="10.1073/pnas.0914157107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 458-765 OF MUTANT GLU-577</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF ARG-577</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="20677" last="20687">
<title>A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor.</title>
<authorList>
<person name="Eathiraj S."/>
<person name="Palma R."/>
<person name="Hirschi M."/>
<person name="Volckova E."/>
<person name="Nakuci E."/>
<person name="Castro J."/>
<person name="Chen C.R."/>
<person name="Chan T.C."/>
<person name="France D.S."/>
<person name="Ashwell M.A."/>
</authorList>
<dbReference type="PubMed" id="21454610"/>
<dbReference type="DOI" id="10.1074/jbc.M110.213736"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 461-765 IN COMPLEX WITH ARQ 069</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="269" last="274">
<title>A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.</title>
<authorList>
<person name="Muenke M."/>
<person name="Schell U."/>
<person name="Hehr A."/>
<person name="Robin N.H."/>
<person name="Losken H.W."/>
<person name="Schinzel A."/>
<person name="Pulleyn L.J."/>
<person name="Rutland P."/>
<person name="Reardon W."/>
<person name="Malcolm S."/>
<person name="Winter R.M."/>
</authorList>
<dbReference type="PubMed" id="7874169"/>
<dbReference type="DOI" id="10.1038/ng1194-269"/>
</citation>
<scope>VARIANT PS ARG-252</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2000" name="Cytogenet. Cell Genet." volume="91" first="138" last="140">
<title>An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly.</title>
<authorList>
<person name="Kress W."/>
<person name="Petersen B."/>
<person name="Collmann H."/>
<person name="Grimm T."/>
</authorList>
<dbReference type="PubMed" id="11173846"/>
</citation>
<scope>VARIANT TRIGNO1 THR-300</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2003" name="Nat. Genet." volume="33" first="463" last="465">
<title>Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.</title>
<authorList>
<person name="Dode C."/>
<person name="Levilliers J."/>
<person name="Dupont J.-M."/>
<person name="De Paepe A."/>
<person name="Le Du N."/>
<person name="Soussi-Yanicostas N."/>
<person name="Coimbra R.S."/>
<person name="Delmaghani S."/>
<person name="Compain-Nouaille S."/>
<person name="Baverel F."/>
<person name="Pecheux C."/>
<person name="Le Tessier D."/>
<person name="Cruaud C."/>
<person name="Delpech M."/>
<person name="Speleman F."/>
<person name="Vermeulen S."/>
<person name="Amalfitano A."/>
<person name="Bachelot Y."/>
<person name="Bouchard P."/>
<person name="Cabrol S."/>
<person name="Carel J.-C."/>
<person name="Delemarre-van de Waal H."/>
<person name="Goulet-Salmon B."/>
<person name="Kottler M.-L."/>
<person name="Richard O."/>
<person name="Sanchez-Franco F."/>
<person name="Saura R."/>
<person name="Young J."/>
<person name="Petit C."/>
<person name="Hardelin J.-P."/>
</authorList>
<dbReference type="PubMed" id="12627230"/>
<dbReference type="DOI" id="10.1038/ng1122"/>
</citation>
<scope>VARIANTS HH2 ASP-97; CYS-99; SER-167; TYR-277; MET-607; ARG-666; ARG-719 AND SER-772</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="1079" last="1088">
<title>Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.</title>
<authorList>
<person name="Sato N."/>
<person name="Katsumata N."/>
<person name="Kagami M."/>
<person name="Hasegawa T."/>
<person name="Hori N."/>
<person name="Kawakita S."/>
<person name="Minowada S."/>
<person name="Shimotsuka A."/>
<person name="Shishiba Y."/>
<person name="Yokozawa M."/>
<person name="Yasuda T."/>
<person name="Nagasaki K."/>
<person name="Hasegawa D."/>
<person name="Hasegawa Y."/>
<person name="Tachibana K."/>
<person name="Naiki Y."/>
<person name="Horikawa R."/>
<person name="Tanaka T."/>
<person name="Ogata T."/>
</authorList>
<dbReference type="PubMed" id="15001591"/>
<dbReference type="DOI" id="10.1210/jc.2003-030476"/>
</citation>
<scope>VARIANT HH2 SER-745</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="76" first="361" last="367">
<title>Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.</title>
<authorList>
<person name="White K.E."/>
<person name="Cabral J.M."/>
<person name="Davis S.I."/>
<person name="Fishburn T."/>
<person name="Evans W.E."/>
<person name="Ichikawa S."/>
<person name="Fields J."/>
<person name="Yu X."/>
<person name="Shaw N.J."/>
<person name="McLellan N.J."/>
<person name="McKeown C."/>
<person name="FitzPatrick D."/>
<person name="Yu K."/>
<person name="Ornitz D.M."/>
<person name="Econs M.J."/>
</authorList>
<dbReference type="PubMed" id="15625620"/>
<dbReference type="DOI" id="10.1086/427956"/>
</citation>
<scope>VARIANTS OGD ILE-330; CYS-374 AND ARG-381</scope>
<scope>CHARACTERIZATION OF VARIANT OGD CYS-374</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="98" last="99">
<title>Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).</title>
<authorList>
<person name="Albuisson J."/>
<person name="Pecheux C."/>
<person name="Carel J.-C."/>
<person name="Lacombe D."/>
<person name="Leheup B."/>
<person name="Lapuzina P."/>
<person name="Bouchard P."/>
<person name="Legius E."/>
<person name="Matthijs G."/>
<person name="Wasniewska M."/>
<person name="Delpech M."/>
<person name="Young J."/>
<person name="Hardelin J.-P."/>
<person name="Dode C."/>
</authorList>
<dbReference type="PubMed" id="15605412"/>
<dbReference type="DOI" id="10.1002/humu.9298"/>
</citation>
<scope>VARIANTS HH2 ILE-102; ALA-129; MET-273 AND THR-520</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2005" name="Hum. Reprod." volume="20" first="2173" last="2178">
<title>Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: report of three families: case report.</title>
<authorList>
<person name="Sato N."/>
<person name="Hasegawa T."/>
<person name="Hori N."/>
<person name="Fukami M."/>
<person name="Yoshimura Y."/>
<person name="Ogata T."/>
</authorList>
<dbReference type="PubMed" id="15845591"/>
<dbReference type="DOI" id="10.1093/humrep/dei052"/>
</citation>
<scope>VARIANTS HH2 ARG-687 AND SER-745</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2006" name="Am. J. Med. Genet. A" volume="140" first="537" last="539">
<title>Extended mutational analyses of FGFR1 in osteoglophonic dysplasia.</title>
<authorList>
<person name="Farrow E.G."/>
<person name="Davis S.I."/>
<person name="Mooney S.D."/>
<person name="Beighton P."/>
<person name="Mascarenhas L."/>
<person name="Gutierrez Y.R."/>
<person name="Pitukcheewanont P."/>
<person name="White K.E."/>
</authorList>
<dbReference type="PubMed" id="16470795"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31106"/>
</citation>
<scope>VARIANTS OGD ILE-330 AND ARG-381</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2006" name="J. Clin. Endocrinol. Metab." volume="91" first="4006" last="4012">
<title>Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.</title>
<authorList>
<person name="Trarbach E.B."/>
<person name="Costa E.M.F."/>
<person name="Versiani B."/>
<person name="de Castro M."/>
<person name="Baptista M.T.M."/>
<person name="Garmes H.M."/>
<person name="de Mendonca B.B."/>
<person name="Latronico A.C."/>
</authorList>
<dbReference type="PubMed" id="16882753"/>
<dbReference type="DOI" id="10.1210/jc.2005-2793"/>
</citation>
<scope>VARIANTS HH2 SER-48; PRO-245; TRP-250; VAL-343; LEU-366; SER-722 AND ILE-795</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2006" name="Mol. Cell. Endocrinol." volume="254" first="60" last="69">
<title>Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.</title>
<authorList>
<person name="Pitteloud N."/>
<person name="Meysing A."/>
<person name="Quinton R."/>
<person name="Acierno J.S. Jr."/>
<person name="Dwyer A.A."/>
<person name="Plummer L."/>
<person name="Fliers E."/>
<person name="Boepple P."/>
<person name="Hayes F."/>
<person name="Seminara S."/>
<person name="Hughes V.A."/>
<person name="Ma J."/>
<person name="Bouloux P."/>
<person name="Mohammadi M."/>
<person name="Crowley W.F. Jr."/>
</authorList>
<dbReference type="PubMed" id="16764984"/>
<dbReference type="DOI" id="10.1016/j.mce.2006.04.021"/>
</citation>
<scope>VARIANTS HH2 CYS-78; ILE-102; HIS-224; ASP-237; GLN-254; MET-273; GLY-274 CYS-339; CYS-346; VAL-538; ARG-703 AND SER-703</scope>
<scope>VARIANT VAL-769</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2006" name="Mol. Cell. Endocrinol." volume="254" first="78" last="83">
<title>Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).</title>
<authorList>
<person name="Zenaty D."/>
<person name="Bretones P."/>
<person name="Lambe C."/>
<person name="Guemas I."/>
<person name="David M."/>
<person name="Leger J."/>
<person name="de Roux N."/>
</authorList>
<dbReference type="PubMed" id="16757108"/>
<dbReference type="DOI" id="10.1016/j.mce.2006.04.006"/>
</citation>
<scope>VARIANTS HH2 SER-178; GLY-622 AND GLN-622</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="6281" last="6286">
<title>Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.</title>
<authorList>
<person name="Pitteloud N."/>
<person name="Acierno J.S. Jr."/>
<person name="Meysing A."/>
<person name="Eliseenkova A.V."/>
<person name="Ma J."/>
<person name="Ibrahimi O.A."/>
<person name="Metzger D.L."/>
<person name="Hayes F.J."/>
<person name="Dwyer A.A."/>
<person name="Hughes V.A."/>
<person name="Yialamas M."/>
<person name="Hall J.E."/>
<person name="Grant E."/>
<person name="Mohammadi M."/>
<person name="Crowley W.F. Jr."/>
</authorList>
<dbReference type="PubMed" id="16606836"/>
<dbReference type="DOI" id="10.1073/pnas.0600962103"/>
</citation>
<scope>VARIANTS HH2 SER-237; HIS-722 AND LYS-724</scope>
<scope>CHARACTERIZATION OF VARIANTS HH2 SER-237; HIS-722 AND LYS-724</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2007" name="Hum. Mutat." volume="28" first="97" last="98">
<title>Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis.</title>
<authorList>
<person name="Dode C."/>
<person name="Fouveaut C."/>
<person name="Mortier G."/>
<person name="Janssens S."/>
<person name="Bertherat J."/>
<person name="Mahoudeau J."/>
<person name="Kottler M.-L."/>
<person name="Chabrolle C."/>
<person name="Gancel A."/>
<person name="Francois I."/>
<person name="Devriendt K."/>
<person name="Wolczynski S."/>
<person name="Pugeat M."/>
<person name="Pineiro-Garcia A."/>
<person name="Murat A."/>
<person name="Bouchard P."/>
<person name="Young J."/>
<person name="Delpech M."/>
<person name="Hardelin J.-P."/>
</authorList>
<dbReference type="PubMed" id="17154279"/>
<dbReference type="DOI" id="10.1002/humu.9470"/>
</citation>
<scope>VARIANTS HH2 PHE-101; TRP-250; ASP-270; ARG-283; CYS-332; ARG-621; PHE-685; PHE-693 AND SER-772</scope>
<scope>VARIANTS LYS-77 AND CYS-822</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-125; THR-252 AND LEU-664</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2009" name="J. Clin. Endocrinol. Metab." volume="94" first="4380" last="4390">
<title>Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.</title>
<authorList>
<person name="Raivio T."/>
<person name="Sidis Y."/>
<person name="Plummer L."/>
<person name="Chen H."/>
<person name="Ma J."/>
<person name="Mukherjee A."/>
<person name="Jacobson-Dickman E."/>
<person name="Quinton R."/>
<person name="Van Vliet G."/>
<person name="Lavoie H."/>
<person name="Hughes V.A."/>
<person name="Dwyer A."/>
<person name="Hayes F.J."/>
<person name="Xu S."/>
<person name="Sparks S."/>
<person name="Kaiser U.B."/>
<person name="Mohammadi M."/>
<person name="Pitteloud N."/>
</authorList>
<dbReference type="PubMed" id="19820032"/>
<dbReference type="DOI" id="10.1210/jc.2009-0179"/>
</citation>
<scope>VARIANTS HH2 CYS-99; SER-117; ASP-228; THR-239; GLN-250; LEU-470; ASN-618 AND PRO-671</scope>
<scope>CHARACTERIZATION OF VARIANTS HH2 CYS-99; SER-117; ASP-228; THR-239; GLN-250; LEU-470; ASN-618 AND PRO-671</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="11524" last="11529">
<title>Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism.</title>
<authorList>
<person name="Tornberg J."/>
<person name="Sykiotis G.P."/>
<person name="Keefe K."/>
<person name="Plummer L."/>
<person name="Hoang X."/>
<person name="Hall J.E."/>
<person name="Quinton R."/>
<person name="Seminara S.B."/>
<person name="Hughes V."/>
<person name="Van Vliet G."/>
<person name="Van Uum S."/>
<person name="Crowley W.F."/>
<person name="Habuchi H."/>
<person name="Kimata K."/>
<person name="Pitteloud N."/>
<person name="Bulow H.E."/>
</authorList>
<dbReference type="PubMed" id="21700882"/>
<dbReference type="DOI" id="10.1073/pnas.1102284108"/>
</citation>
<scope>VARIANT HH2 GLN-250</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2012" name="PLoS Genet." volume="8" first="E1002896" last="E1002896">
<title>SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.</title>
<authorList>
<person name="Hanchate N.K."/>
<person name="Giacobini P."/>
<person name="Lhuillier P."/>
<person name="Parkash J."/>
<person name="Espy C."/>
<person name="Fouveaut C."/>
<person name="Leroy C."/>
<person name="Baron S."/>
<person name="Campagne C."/>
<person name="Vanacker C."/>
<person name="Collier F."/>
<person name="Cruaud C."/>
<person name="Meyer V."/>
<person name="Garcia-Pinero A."/>
<person name="Dewailly D."/>
<person name="Cortet-Rudelli C."/>
<person name="Gersak K."/>
<person name="Metz C."/>
<person name="Chabrier G."/>
<person name="Pugeat M."/>
<person name="Young J."/>
<person name="Hardelin J.P."/>
<person name="Prevot V."/>
<person name="Dode C."/>
</authorList>
<dbReference type="PubMed" id="22927827"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1002896"/>
</citation>
<scope>VARIANT HH2 ARG-687</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="92" first="725" last="743">
<title>Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.</title>
<authorList>
<person name="Miraoui H."/>
<person name="Dwyer A.A."/>
<person name="Sykiotis G.P."/>
<person name="Plummer L."/>
<person name="Chung W."/>
<person name="Feng B."/>
<person name="Beenken A."/>
<person name="Clarke J."/>
<person name="Pers T.H."/>
<person name="Dworzynski P."/>
<person name="Keefe K."/>
<person name="Niedziela M."/>
<person name="Raivio T."/>
<person name="Crowley W.F. Jr."/>
<person name="Seminara S.B."/>
<person name="Quinton R."/>
<person name="Hughes V.A."/>
<person name="Kumanov P."/>
<person name="Young J."/>
<person name="Yialamas M.A."/>
<person name="Hall J.E."/>
<person name="Van Vliet G."/>
<person name="Chanoine J.P."/>
<person name="Rubenstein J."/>
<person name="Mohammadi M."/>
<person name="Tsai P.S."/>
<person name="Sidis Y."/>
<person name="Lage K."/>
<person name="Pitteloud N."/>
</authorList>
<dbReference type="PubMed" id="23643382"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.04.008"/>
</citation>
<scope>VARIANTS HH2 SER-117; ASP-228; THR-239; GLN-250; SER-342; ARG-348; LEU-470; THR-483; ASN-618; LYS-670; GLY-692; HIS-722; LYS-724 AND TYR-768</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2013" name="J. Med. Genet." volume="50" first="585" last="592">
<title>FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly.</title>
<authorList>
<person name="Simonis N."/>
<person name="Migeotte I."/>
<person name="Lambert N."/>
<person name="Perazzolo C."/>
<person name="de Silva D.C."/>
<person name="Dimitrov B."/>
<person name="Heinrichs C."/>
<person name="Janssens S."/>
<person name="Kerr B."/>
<person name="Mortier G."/>
<person name="Van Vliet G."/>
<person name="Lepage P."/>
<person name="Casimir G."/>
<person name="Abramowicz M."/>
<person name="Smits G."/>
<person name="Vilain C."/>
</authorList>
<dbReference type="PubMed" id="23812909"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2013-101603"/>
</citation>
<scope>INVOLVEMENT IN HRTFDS</scope>
<scope>VARIANTS HRTFDS SER-165; SER-191; ARG-490; TYR-623; LYS-628 AND TYR-725</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2014" name="Am. J. Med. Genet. A" volume="164" first="2356" last="2359">
<title>Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: A case of gonadal mosaicism.</title>
<authorList>
<person name="Dhamija R."/>
<person name="Kirmani S."/>
<person name="Wang X."/>
<person name="Ferber M.J."/>
<person name="Wieben E.D."/>
<person name="Lazaridis K.N."/>
<person name="Babovic-Vuksanovic D."/>
</authorList>
<dbReference type="PubMed" id="24888332"/>
<dbReference type="DOI" id="10.1002/ajmg.a.36621"/>
</citation>
<scope>VARIANT HRTFDS THR-627</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2014" name="J. Clin. Endocrinol. Metab." volume="99" first="E2138" last="2143">
<title>The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.</title>
<authorList>
<person name="Marcos S."/>
<person name="Sarfati J."/>
<person name="Leroy C."/>
<person name="Fouveaut C."/>
<person name="Parent P."/>
<person name="Metz C."/>
<person name="Wolczynski S."/>
<person name="Gerard M."/>
<person name="Bieth E."/>
<person name="Kurtz F."/>
<person name="Verier-Mine O."/>
<person name="Perrin L."/>
<person name="Archambeaud F."/>
<person name="Cabrol S."/>
<person name="Rodien P."/>
<person name="Hove H."/>
<person name="Prescott T."/>
<person name="Lacombe D."/>
<person name="Christin-Maitre S."/>
<person name="Touraine P."/>
<person name="Hieronimus S."/>
<person name="Dewailly D."/>
<person name="Young J."/>
<person name="Pugeat M."/>
<person name="Hardelin J.P."/>
<person name="Dode C."/>
</authorList>
<dbReference type="PubMed" id="25077900"/>
<dbReference type="DOI" id="10.1210/jc.2014-2110"/>
</citation>
<scope>VARIANTS HH2 ARG-70; ILE-116; ALA-174; GLN-250 AND ARG-348</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2015" name="Fertil. Steril.">
<title>Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.</title>
<authorList>
<person name="Goncalves C."/>
<person name="Bastos M."/>
<person name="Pignatelli D."/>
<person name="Borges T."/>
<person name="Araguees J.M."/>
<person name="Fonseca F."/>
<person name="Pereira B.D."/>
<person name="Socorro S."/>
<person name="Lemos M.C."/>
</authorList>
<dbReference type="PubMed" id="26277103"/>
<dbReference type="DOI" id="10.1016/j.fertnstert.2015.07.1142"/>
</citation>
<scope>VARIANTS HH2 CYS-4; CYS-96 AND VAL-719</scope>
<scope>VARIANT HH2 THR-353 (ISOFORM 19)</scope>
</reference>
<comment type="function">
<text evidence="13 20 23 24 26 27 30 41 50 53 55 56 57 58 62 63 67 77 78">Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="17 26 30 55 56 58 62 77">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="55 56 65 77">Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by sequential autophosphorylation on tyrosine residues. Inhibited by ARQ 069; this compound maintains the kinase in an inactive conformation and inhibits autophosphorylation. Inhibited by PD173074.</text>
</comment>
<comment type="subunit">
<text evidence="13 18 24 26 30 40 41 47 49 53 54 59 61 64 67 78 79">Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF5, FGF6, FGF8, FGF10, FGF19, FGF21, FGF22 and FGF23 (in vitro) (PubMed:1697263, PubMed:1722683, PubMed:8663044, PubMed:9655399, PubMed:12181353, PubMed:16597617, PubMed:17623664). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19, FGF21 and FGF23 (PubMed:19966287). Interacts (phosphorylated on Tyr-766) with PLCG1 (via SH2 domains) (PubMed:1656221, PubMed:1379697, PubMed:21765395). Interacts with FRS2 (PubMed:21765395). Interacts with RPS6KA1 (PubMed:15117958). Interacts (via C-terminus) with NEDD4 (via WW3 domain) (PubMed:21765395). Interacts with KL (By similarity). Interacts with SHB (via SH2 domain) (PubMed:12181353). Interacts with GRB10 (PubMed:10454568). Interacts with ANOS1; this interaction does not interfere with FGF2-binding to FGFR1, but prevents binding of heparin-bound FGF2 (PubMed:19696444). Interacts with SOX2 and SOX3. Interacts with FLRT1, FLRT2 and FLRT3 (By similarity). Found in a ternary complex with FGF1 and ITGAV:ITGB3 (PubMed:20422052, PubMed:18441324).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-1028277"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-5272188">
<id>P23352</id>
<label>ANOS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-698068">
<id>P05230</id>
<label>FGF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-977447">
<id>P09038</id>
<label>FGF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-7639197">
<id>O88900</id>
<label>Grb14</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-6570214">
<id>P08908</id>
<label>HTR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-726944">
<id>P46934</id>
<label>NEDD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-1391643">
<id>Q8IVI9</id>
<label>NOSTRIN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028277"/>
<interactant intactId="EBI-520788">
<id>P10686</id>
<label>Plcg1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<text>After ligand binding, both receptor and ligand are rapidly internalized. Can translocate to the nucleus after internalization, or by translocation from the endoplasmic reticulum or Golgi apparatus to the cytosol, and from there to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P11362-1</id>
<name>1</name>
<name>Alpha A1</name>
<name>IV</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P11362-8</id>
<name>2</name>
<name>Alpha A2</name>
<sequence type="described" ref="VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-17</id>
<name>3</name>
<name>Alpha A3</name>
<sequence type="described" ref="VSP_009836 VSP_009837"/>
</isoform>
<isoform>
<id>P11362-2</id>
<name>4</name>
<name>Alpha B1</name>
<sequence type="described" ref="VSP_002960"/>
</isoform>
<isoform>
<id>P11362-9</id>
<name>5</name>
<name>Alpha B2</name>
<sequence type="described" ref="VSP_002960 VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-3</id>
<name>6</name>
<name>Beta A1</name>
<name>II</name>
<name>H2</name>
<sequence type="described" ref="VSP_002958"/>
</isoform>
<isoform>
<id>P11362-10</id>
<name>7</name>
<name>Beta A2</name>
<sequence type="described" ref="VSP_002958 VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-4</id>
<name>8</name>
<name>Beta B1</name>
<sequence type="described" ref="VSP_002958 VSP_002960"/>
</isoform>
<isoform>
<id>P11362-11</id>
<name>9</name>
<name>Beta B2</name>
<sequence type="described" ref="VSP_002958 VSP_002960 VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-5</id>
<name>10</name>
<name>Gamma A1</name>
<sequence type="described" ref="VSP_002957"/>
</isoform>
<isoform>
<id>P11362-12</id>
<name>11</name>
<name>Gamma A2</name>
<sequence type="described" ref="VSP_002957 VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-6</id>
<name>12</name>
<name>Gamma B1</name>
<sequence type="described" ref="VSP_002957 VSP_002960"/>
</isoform>
<isoform>
<id>P11362-13</id>
<name>13</name>
<name>Gamma B2</name>
<sequence type="described" ref="VSP_002957 VSP_002960 VSP_009842 VSP_009843"/>
</isoform>
<isoform>
<id>P11362-7</id>
<name>14</name>
<name>A</name>
<name>III</name>
<sequence type="described" ref="VSP_002959"/>
</isoform>
<isoform>
<id>P11362-14</id>
<name>15</name>
<name>I</name>
<name>H3</name>
<sequence type="described" ref="VSP_002958 VSP_002959"/>
</isoform>
<isoform>
<id>P11362-15</id>
<name>16</name>
<name>V</name>
<sequence type="described" ref="VSP_009838 VSP_009839"/>
</isoform>
<isoform>
<id>P11362-16</id>
<name>17</name>
<name>H4</name>
<sequence type="described" ref="VSP_002958 VSP_009840 VSP_009841"/>
</isoform>
<isoform>
<id>P11362-18</id>
<name>18</name>
<name>H5</name>
<sequence type="described" ref="VSP_002958 VSP_002959 VSP_009840 VSP_009841"/>
</isoform>
<isoform>
<id>P11362-19</id>
<name>19</name>
<sequence type="described" ref="VSP_038470 VSP_002959 VSP_038471"/>
<text evidence="73">Variant in position: 353:A->T (in HH2, unknown pathological significance).</text>
</isoform>
<isoform>
<id>P11362-20</id>
<name>20</name>
<sequence type="described" ref="VSP_041916 VSP_041918"/>
</isoform>
<isoform>
<id>P11362-21</id>
<name>21</name>
<sequence type="described" ref="VSP_041917 VSP_002959"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="39">Detected in astrocytoma, neuroblastoma and adrenal cortex cell lines. Some isoforms are detected in foreskin fibroblast cell lines, however isoform 17, isoform 18 and isoform 19 are not detected in these cells.</text>
</comment>
<comment type="domain">
<text>The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Isoforms lacking the first Ig-like domain have higher affinity for fibroblast growth factors (FGF) and heparan sulfate proteoglycans than isoforms with all three Ig-like domains.</text>
</comment>
<comment type="PTM">
<text evidence="38 56 58 77">Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer and proceeds in a highly ordered manner. Initial autophosphorylation at Tyr-653 increases the kinase activity by a factor of 50 to 100. After this, Tyr-583 becomes phosphorylated, followed by phosphorylation of Tyr-463, Tyr-766, Tyr-583 and Tyr-585. In a third stage, Tyr-654 is autophosphorylated, resulting in a further tenfold increase of kinase activity. Phosphotyrosine residues provide docking sites for interacting proteins and so are crucial for FGFR1 function and its regulation.</text>
</comment>
<comment type="PTM">
<text evidence="55 67">Ubiquitinated. FGFR1 is rapidly ubiquitinated by NEDD4 after autophosphorylation, leading to internalization and lysosomal degradation. CBL is recruited to activated FGFR1 via FRS2 and GRB2, and mediates ubiquitination and subsequent degradation of FGFR1.</text>
</comment>
<comment type="PTM">
<text evidence="35 37 50">N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus.</text>
</comment>
<comment type="disease" evidence="76">
<disease id="DI-00924">
<name>Pfeiffer syndrome</name>
<acronym>PS</acronym>
<description>A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).</description>
<dbReference type="MIM" id="101600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25 28 32 34 42 43 44 45 48 60 66 68 69 72 73">
<disease id="DI-00618">
<name>Hypogonadotropic hypogonadism 2 with or without anosmia</name>
<acronym>HH2</acronym>
<description>A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH).</description>
<dbReference type="MIM" id="147950"/>
</disease>
<text evidence="69">The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FGFR1 also have a mutation other HH-associated genes including DUSP6, FGF8, FGF17, FLRT3, GNRH1, GNRHR, HS6ST1, IL17RD, ANOS1, KISS1R, NSMF, PROKR2, SPRY4 and TACR3 (PubMed:23643382).</text>
</comment>
<comment type="disease" evidence="33 36">
<disease id="DI-02110">
<name>Osteoglophonic dysplasia</name>
<acronym>OGD</acronym>
<description>Characterized by craniosynostosis, prominent supraorbital ridge, and depressed nasal bridge, as well as by rhizomelic dwarfism and nonossifying bone lesions. Inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="166250"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="70 71">
<disease id="DI-03909">
<name>Hartsfield syndrome</name>
<acronym>HRTFDS</acronym>
<description>A syndrome characterized by the triad of holoprosencephaly, ectrodactyly, and cleft/lip palate. Profound mental retardation is also present. Multiple other congenital anomalies usually occur.</description>
<dbReference type="MIM" id="615465"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-02068">
<name>Trigonocephaly 1</name>
<acronym>TRIGNO1</acronym>
<description>A keel-shaped deformation of the forehead, caused by premature fusion of the metopic sutures. It results in a triangular shape of the head.</description>
<dbReference type="MIM" id="190440"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="80">A chromosomal aberration involving FGFR1 may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Translocation t(8;13)(p11;q12) with ZMYM2. SCLL usually presents as lymphoblastic lymphoma in association with a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow.</text>
</comment>
<comment type="disease">
<text evidence="19 29 46 52 81">A chromosomal aberration involving FGFR1 may be a cause of stem cell myeloproliferative disorder (MPD). Translocation t(6;8)(q27;p11) with FGFR1OP. Insertion ins(12;8)(p11;p11p22) with FGFR1OP2. MPD is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion proteins FGFR1OP2-FGFR1, FGFR1OP-FGFR1 or FGFR1-FGFR1OP may exhibit constitutive kinase activity and be responsible for the transforming activity.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving FGFR1 may be a cause of stem cell myeloproliferative disorder (MPD). Translocation t(8;9)(p12;q33) with CNTRL. MPD is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion protein CNTRL-FGFR1 is found in the cytoplasm, exhibits constitutive kinase activity and may be responsible for the transforming activity.</text>
</comment>
<comment type="disease" evidence="56 74">
<disease id="DI-04665">
<name>Encephalocraniocutaneous lipomatosis</name>
<acronym>ECCL</acronym>
<description>A sporadically occurring, neurocutaneous disorder characterized by ocular anomalies, skin lesions, and central nervous system anomalies. Clinical features include a well-demarcated hairless fatty nevus on the scalp, benign ocular tumors, intracranial and intraspinal lipomas, and congenital abnormalities of the meninges. Seizures, spasticity, and intellectual disability can be present.</description>
<dbReference type="MIM" id="613001"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-00602">
<name>Jackson-Weiss syndrome</name>
<acronym>JWS</acronym>
<description>An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence.</description>
<dbReference type="MIM" id="123150"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="95">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92156" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/FGFR1ID113.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/fgfr1/"/>
</comment>
<dbReference type="EC" id="2.7.10.1" evidence="26 30 55 56 58 62 77"/>
<dbReference type="EMBL" id="M37722">
<property type="protein sequence ID" value="AAA75007.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52833">
<property type="protein sequence ID" value="CAA37015.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34185">
<property type="protein sequence ID" value="AAA35836.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34186">
<property type="protein sequence ID" value="AAA35837.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34187">
<property type="protein sequence ID" value="AAA35838.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34188">
<property type="protein sequence ID" value="AAA35839.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X51803">
<property type="protein sequence ID" value="CAA36101.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34641">
<property type="protein sequence ID" value="AAA35835.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M60485">
<property type="protein sequence ID" value="AAA35840.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57118">
<property type="protein sequence ID" value="CAA40400.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57119">
<property type="protein sequence ID" value="CAA40401.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57120">
<property type="protein sequence ID" value="CAA40402.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57121">
<property type="protein sequence ID" value="CAA40403.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57122">
<property type="protein sequence ID" value="CAA40404.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M63887">
<property type="protein sequence ID" value="AAA35958.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M63888">
<property type="protein sequence ID" value="AAA35959.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M63889">
<property type="protein sequence ID" value="AAA35960.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X66945">
<property type="protein sequence ID" value="CAA47375.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ809917">
<property type="protein sequence ID" value="ACO38646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291754">
<property type="protein sequence ID" value="BAF84443.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292470">
<property type="protein sequence ID" value="BAF85159.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK309947">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208919">
<property type="protein sequence ID" value="BAD92156.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222718">
<property type="protein sequence ID" value="BAD96438.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY585209">
<property type="protein sequence ID" value="AAS79322.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087623">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015035">
<property type="protein sequence ID" value="AAH15035.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018128">
<property type="protein sequence ID" value="AAH18128.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC091494">
<property type="protein sequence ID" value="AAH91494.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y00665">
<property type="protein sequence ID" value="CAA68679.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43730.1">
<molecule id="P11362-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43731.1">
<molecule id="P11362-14"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43732.1">
<molecule id="P11362-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55221.1">
<molecule id="P11362-20"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55222.1">
<molecule id="P11362-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55223.1">
<molecule id="P11362-21"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6107.2">
<molecule id="P11362-1"/>
</dbReference>
<dbReference type="PIR" id="A41266">
<property type="entry name" value="A41266"/>
</dbReference>
<dbReference type="PIR" id="C36464">
<property type="entry name" value="C36464"/>
</dbReference>
<dbReference type="PIR" id="C40862">
<property type="entry name" value="C40862"/>
</dbReference>
<dbReference type="PIR" id="S11692">
<property type="entry name" value="TVHUFG"/>
</dbReference>
<dbReference type="PIR" id="S19167">
<property type="entry name" value="A40862"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167534.1">
<molecule id="P11362-2"/>
<property type="nucleotide sequence ID" value="NM_001174063.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167535.1">
<molecule id="P11362-20"/>
<property type="nucleotide sequence ID" value="NM_001174064.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167536.1">
<molecule id="P11362-7"/>
<property type="nucleotide sequence ID" value="NM_001174065.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167537.1">
<molecule id="P11362-3"/>
<property type="nucleotide sequence ID" value="NM_001174066.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167538.1">
<molecule id="P11362-21"/>
<property type="nucleotide sequence ID" value="NM_001174067.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_056934.2">
<molecule id="P11362-7"/>
<property type="nucleotide sequence ID" value="NM_015850.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_075593.1">
<molecule id="P11362-3"/>
<property type="nucleotide sequence ID" value="NM_023105.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_075594.1">
<molecule id="P11362-14"/>
<property type="nucleotide sequence ID" value="NM_023106.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_075598.2">
<molecule id="P11362-1"/>
<property type="nucleotide sequence ID" value="NM_023110.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.264887"/>
<dbReference type="PDB" id="1AGW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="1CVS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C/D=141-365"/>
</dbReference>
<dbReference type="PDB" id="1EVT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C/D=141-365"/>
</dbReference>
<dbReference type="PDB" id="1FGI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="1FGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="1FQ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C/D=141-365"/>
</dbReference>
<dbReference type="PDB" id="1XR0">
<property type="method" value="NMR"/>
<property type="chains" value="A=409-430"/>
</dbReference>
<dbReference type="PDB" id="2CR3">
<property type="method" value="NMR"/>
<property type="chains" value="A=38-123"/>
</dbReference>
<dbReference type="PDB" id="2FGI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="3C4F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=464-765"/>
</dbReference>
<dbReference type="PDB" id="3DPK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=577-615"/>
</dbReference>
<dbReference type="PDB" id="3GQI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=458-774"/>
</dbReference>
<dbReference type="PDB" id="3GQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C=458-774"/>
</dbReference>
<dbReference type="PDB" id="3JS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="3KRJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=577-597"/>
</dbReference>
<dbReference type="PDB" id="3KRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=577-597"/>
</dbReference>
<dbReference type="PDB" id="3KXX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D=458-765"/>
</dbReference>
<dbReference type="PDB" id="3KY2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="3OJV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C/D=142-365"/>
</dbReference>
<dbReference type="PDB" id="3RHX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/B=461-765"/>
</dbReference>
<dbReference type="PDB" id="3TT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="4F63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4F64">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4F65">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4NK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4NKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4NKS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4RWI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4RWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4RWK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4RWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4UWB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4UWC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4UWY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4V01">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4V04">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4V05">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="4WUN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=459-765"/>
</dbReference>
<dbReference type="PDB" id="4ZSA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="5A46">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.63"/>
<property type="chains" value="A/B=437-822"/>
</dbReference>
<dbReference type="PDB" id="5A4C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A/B=461-765"/>
</dbReference>
<dbReference type="PDB" id="5AM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="5AM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="5B7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=456-765"/>
</dbReference>
<dbReference type="PDB" id="5EW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A/B=458-765"/>
</dbReference>
<dbReference type="PDB" id="5FLF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/C/D/E=458-765"/>
</dbReference>
<dbReference type="PDB" id="5UQ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=459-765"/>
</dbReference>
<dbReference type="PDBsum" id="1AGW"/>
<dbReference type="PDBsum" id="1CVS"/>
<dbReference type="PDBsum" id="1EVT"/>
<dbReference type="PDBsum" id="1FGI"/>
<dbReference type="PDBsum" id="1FGK"/>
<dbReference type="PDBsum" id="1FQ9"/>
<dbReference type="PDBsum" id="1XR0"/>
<dbReference type="PDBsum" id="2CR3"/>
<dbReference type="PDBsum" id="2FGI"/>
<dbReference type="PDBsum" id="3C4F"/>
<dbReference type="PDBsum" id="3DPK"/>
<dbReference type="PDBsum" id="3GQI"/>
<dbReference type="PDBsum" id="3GQL"/>
<dbReference type="PDBsum" id="3JS2"/>
<dbReference type="PDBsum" id="3KRJ"/>
<dbReference type="PDBsum" id="3KRL"/>
<dbReference type="PDBsum" id="3KXX"/>
<dbReference type="PDBsum" id="3KY2"/>
<dbReference type="PDBsum" id="3OJV"/>
<dbReference type="PDBsum" id="3RHX"/>
<dbReference type="PDBsum" id="3TT0"/>
<dbReference type="PDBsum" id="4F63"/>
<dbReference type="PDBsum" id="4F64"/>
<dbReference type="PDBsum" id="4F65"/>
<dbReference type="PDBsum" id="4NK9"/>
<dbReference type="PDBsum" id="4NKA"/>
<dbReference type="PDBsum" id="4NKS"/>
<dbReference type="PDBsum" id="4RWI"/>
<dbReference type="PDBsum" id="4RWJ"/>
<dbReference type="PDBsum" id="4RWK"/>
<dbReference type="PDBsum" id="4RWL"/>
<dbReference type="PDBsum" id="4UWB"/>
<dbReference type="PDBsum" id="4UWC"/>
<dbReference type="PDBsum" id="4UWY"/>
<dbReference type="PDBsum" id="4V01"/>
<dbReference type="PDBsum" id="4V04"/>
<dbReference type="PDBsum" id="4V05"/>
<dbReference type="PDBsum" id="4WUN"/>
<dbReference type="PDBsum" id="4ZSA"/>
<dbReference type="PDBsum" id="5A46"/>
<dbReference type="PDBsum" id="5A4C"/>
<dbReference type="PDBsum" id="5AM6"/>
<dbReference type="PDBsum" id="5AM7"/>
<dbReference type="PDBsum" id="5B7V"/>
<dbReference type="PDBsum" id="5EW8"/>
<dbReference type="PDBsum" id="5FLF"/>
<dbReference type="PDBsum" id="5UQ0"/>
<dbReference type="ProteinModelPortal" id="P11362"/>
<dbReference type="SMR" id="P11362"/>
<dbReference type="BioGrid" id="108551">
<property type="interactions" value="87"/>
</dbReference>
<dbReference type="DIP" id="DIP-4019N"/>
<dbReference type="IntAct" id="P11362">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="MINT-1499363"/>
<dbReference type="STRING" id="9606.ENSP00000393312"/>
<dbReference type="BindingDB" id="P11362"/>
<dbReference type="ChEMBL" id="CHEMBL3650"/>
<dbReference type="DrugBank" id="DB08577">
<property type="generic name" value="3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00039">
<property type="generic name" value="Palifermin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB02058">
<property type="generic name" value="SU4984"/>
</dbReference>
<dbReference type="DrugBank" id="DB05014">
<property type="generic name" value="XL999"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1808"/>
<dbReference type="iPTMnet" id="P11362"/>
<dbReference type="PhosphoSitePlus" id="P11362"/>
<dbReference type="SwissPalm" id="P11362"/>
<dbReference type="BioMuta" id="FGFR1"/>
<dbReference type="DMDM" id="120046"/>
<dbReference type="EPD" id="P11362"/>
<dbReference type="MaxQB" id="P11362"/>
<dbReference type="PaxDb" id="P11362"/>
<dbReference type="PeptideAtlas" id="P11362"/>
<dbReference type="PRIDE" id="P11362"/>
<dbReference type="DNASU" id="2260"/>
<dbReference type="Ensembl" id="ENST00000326324">
<molecule id="P11362-14"/>
<property type="protein sequence ID" value="ENSP00000327229"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000335922">
<molecule id="P11362-20"/>
<property type="protein sequence ID" value="ENSP00000337247"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000356207">
<molecule id="P11362-3"/>
<property type="protein sequence ID" value="ENSP00000348537"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397091">
<molecule id="P11362-7"/>
<property type="protein sequence ID" value="ENSP00000380280"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397108">
<molecule id="P11362-7"/>
<property type="protein sequence ID" value="ENSP00000380297"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397113">
<molecule id="P11362-7"/>
<property type="protein sequence ID" value="ENSP00000380302"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000425967">
<molecule id="P11362-21"/>
<property type="protein sequence ID" value="ENSP00000393312"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000447712">
<molecule id="P11362-1"/>
<property type="protein sequence ID" value="ENSP00000400162"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000484370">
<molecule id="P11362-15"/>
<property type="protein sequence ID" value="ENSP00000433163"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000532791">
<molecule id="P11362-2"/>
<property type="protein sequence ID" value="ENSP00000432972"/>
<property type="gene ID" value="ENSG00000077782"/>
</dbReference>
<dbReference type="GeneID" id="2260"/>
<dbReference type="KEGG" id="hsa:2260"/>
<dbReference type="UCSC" id="uc003xlp.4">
<molecule id="P11362-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2260"/>
<dbReference type="DisGeNET" id="2260"/>
<dbReference type="GeneCards" id="FGFR1"/>
<dbReference type="GeneReviews" id="FGFR1"/>
<dbReference type="HGNC" id="HGNC:3688">
<property type="gene designation" value="FGFR1"/>
</dbReference>
<dbReference type="HPA" id="CAB033614"/>
<dbReference type="HPA" id="HPA056402"/>
<dbReference type="HPA" id="HPA076274"/>
<dbReference type="MalaCards" id="FGFR1"/>
<dbReference type="MIM" id="101600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="123150">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="136350">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="147950">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="166250">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="190440">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613001">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615465">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P11362"/>
<dbReference type="OpenTargets" id="ENSG00000077782"/>
<dbReference type="Orphanet" id="251579">
<property type="disease" value="Giant cell glioblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="251576">
<property type="disease" value="Gliosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="2117">
<property type="disease" value="Hartsfield-Bixler-Demyer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="2227">
<property type="disease" value="Hypodontia"/>
</dbReference>
<dbReference type="Orphanet" id="3366">
<property type="disease" value="Isolated trigonocephaly"/>
</dbReference>
<dbReference type="Orphanet" id="478">
<property type="disease" value="Kallmann syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="168953">
<property type="disease" value="Myeloid neoplasm associated with FGFR1 rearrangement"/>
</dbReference>
<dbReference type="Orphanet" id="432">
<property type="disease" value="Normosmic congenital hypogonadotropic hypogonadism"/>
</dbReference>
<dbReference type="Orphanet" id="99798">
<property type="disease" value="Oligodontia"/>
</dbReference>
<dbReference type="Orphanet" id="2645">
<property type="disease" value="Osteoglophonic dwarfism"/>
</dbReference>
<dbReference type="Orphanet" id="93258">
<property type="disease" value="Pfeiffer syndrome type 1"/>
</dbReference>
<dbReference type="Orphanet" id="251612">
<property type="disease" value="Pilocytic astrocytoma"/>
</dbReference>
<dbReference type="Orphanet" id="314950">
<property type="disease" value="Primary hypereosinophilic syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="3157">
<property type="disease" value="Septo-optic dysplasia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28127"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000263410"/>
<dbReference type="HOVERGEN" id="HBG000345"/>
<dbReference type="InParanoid" id="P11362"/>
<dbReference type="KO" id="K04362"/>
<dbReference type="OMA" id="KVRDHMW"/>
<dbReference type="OrthoDB" id="EOG091G0CQZ"/>
<dbReference type="PhylomeDB" id="P11362"/>
<dbReference type="TreeFam" id="TF316307"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839120">
<property type="pathway name" value="Signaling by FGFR1 amplification mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839122">
<property type="pathway name" value="Signaling by activated point mutants of FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190370">
<property type="pathway name" value="FGFR1b ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190373">
<property type="pathway name" value="FGFR1c ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190374">
<property type="pathway name" value="FGFR1c and Klotho ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-375165">
<property type="pathway name" value="NCAM signaling for neurite out-growth"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654219">
<property type="pathway name" value="Phospholipase C-mediated cascade: FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654687">
<property type="pathway name" value="Downstream signaling of activated FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654688">
<property type="pathway name" value="SHC-mediated cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654689">
<property type="pathway name" value="PI-3K cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654693">
<property type="pathway name" value="FRS-mediated FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654726">
<property type="pathway name" value="Negative regulation of FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853336">
<property type="pathway name" value="Signaling by plasma membrane FGFR1 fusions"/>
</dbReference>
<dbReference type="SignaLink" id="P11362"/>
<dbReference type="SIGNOR" id="P11362"/>
<dbReference type="ChiTaRS" id="FGFR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P11362"/>
<dbReference type="GeneWiki" id="Fibroblast_growth_factor_receptor_1"/>
<dbReference type="GenomeRNAi" id="2260"/>
<dbReference type="PMAP-CutDB" id="P11362"/>
<dbReference type="PRO" id="PR:P11362"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000077782"/>
<dbReference type="CleanEx" id="HS_FGFR1"/>
<dbReference type="CleanEx" id="HS_FLG"/>
<dbReference type="ExpressionAtlas" id="P11362">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P11362">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016303">
<property type="term" value="F:1-phosphatidylinositol-3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0017134">
<property type="term" value="F:fibroblast growth factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005007">
<property type="term" value="F:fibroblast growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090722">
<property type="term" value="F:receptor-receptor interaction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060117">
<property type="term" value="P:auditory receptor cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060445">
<property type="term" value="P:branching involved in salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030326">
<property type="term" value="P:embryonic limb morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035607">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042472">
<property type="term" value="P:inner ear morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060484">
<property type="term" value="P:lung-associated mesenchyme development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048762">
<property type="term" value="P:mesenchymal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030901">
<property type="term" value="P:midbrain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042474">
<property type="term" value="P:middle ear morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090272">
<property type="term" value="P:negative regulation of fibroblast growth factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001759">
<property type="term" value="P:organ induction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042473">
<property type="term" value="P:outer ear morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048339">
<property type="term" value="P:paraxial mesoderm development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060045">
<property type="term" value="P:positive regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000546">
<property type="term" value="P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090080">
<property type="term" value="P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903465">
<property type="term" value="P:positive regulation of mitotic cell cycle DNA replication"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045666">
<property type="term" value="P:positive regulation of neuron differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000830">
<property type="term" value="P:positive regulation of parathyroid hormone secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010518">
<property type="term" value="P:positive regulation of phospholipase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010863">
<property type="term" value="P:positive regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060665">
<property type="term" value="P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001239">
<property type="term" value="P:regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048378">
<property type="term" value="P:regulation of lateral mesodermal cell fate specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007605">
<property type="term" value="P:sensory perception of sound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001501">
<property type="term" value="P:skeletal system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048705">
<property type="term" value="P:skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007037">
<property type="term" value="P:vacuolar phosphate transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021847">
<property type="term" value="P:ventricular zone neuroblast division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070640">
<property type="term" value="P:vitamin D3 metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd05098">
<property type="entry name" value="PTKc_FGFR1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="InterPro" id="IPR028174">
<property type="entry name" value="FGF_rcpt_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016248">
<property type="entry name" value="FGF_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000628">
<property type="entry name" value="FGFR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0989">Craniosynostosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0358">Heparin-binding</keyword>
<keyword id="KW-0370">Holoprosencephaly</keyword>
<keyword id="KW-1016">Hypogonadotropic hypogonadism</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0956">Kallmann syndrome</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Fibroblast growth factor receptor 1" id="PRO_0000016780">
<location>
<begin position="22"/>
<end position="822"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="14">
<location>
<begin position="22"/>
<end position="376"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="14">
<location>
<begin position="377"/>
<end position="397"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="14">
<location>
<begin position="398"/>
<end position="822"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="119"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="158"/>
<end position="246"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="255"/>
<end position="357"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="16">
<location>
<begin position="478"/>
<end position="767"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="484"/>
<end position="490"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="562"/>
<end position="564"/>
</location>
</feature>
<feature type="region of interest" description="Heparin-binding">
<location>
<begin position="160"/>
<end position="177"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="16 17 56">
<location>
<position position="623"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="514"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="568"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="627"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="641"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form CNTRL-FGFR1 OR FGFR1-CNTRL fusion proteins" evidence="19">
<location>
<begin position="428"/>
<end position="429"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form FGFR1OP-FGFR1 or FGFR1-FGFR1OP fusion proteins" evidence="81">
<location>
<begin position="428"/>
<end position="429"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form FGFR1OP2-FGFR1" evidence="29 46 52">
<location>
<begin position="428"/>
<end position="429"/>
</location>
</feature>
<feature type="site" description="Mediates interaction with PLCG1 and SHB">
<location>
<position position="766"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56 77">
<location>
<position position="463"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56 77">
<location>
<position position="583"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56 77">
<location>
<position position="585"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56 58 77">
<location>
<position position="653"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56 58 77">
<location>
<position position="654"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="56 77">
<location>
<position position="730"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="58">
<location>
<position position="766"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="77"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="117"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="227"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="240"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="35">
<location>
<position position="296"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="317"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="330"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="55"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="178"/>
<end position="230"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="277"/>
<end position="341"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10, isoform 11, isoform 12 and isoform 13." id="VSP_002957" evidence="89">
<location>
<begin position="1"/>
<end position="160"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 20." id="VSP_041916" evidence="94">
<original>MWSWKCLLFWAVLVTATLCTARPSPTLPEQ</original>
<variation>MAAVTRDFGEMLLHSGRVLPAE</variation>
<location>
<begin position="1"/>
<end position="30"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 21." id="VSP_041917" evidence="83">
<original>M</original>
<variation>MEARVSLKRRIELTVEYPWRCGALSPTSNCRTGM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6, isoform 7, isoform 8, isoform 9, isoform 15, isoform 17 and isoform 18." id="VSP_002958" evidence="83 84 85 89 91 92 93">
<location>
<begin position="31"/>
<end position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_009836" evidence="89">
<original>QPWGAPVEVESFLVHPGDLLQLRCRLRDDV</original>
<variation>CPDLQEAKSCSASFHSITPLPFGLGTRLSD</variation>
<location>
<begin position="32"/>
<end position="61"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_009837" evidence="89">
<location>
<begin position="62"/>
<end position="822"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 19." id="VSP_038470" evidence="86 90">
<original>S</original>
<variation>SVPI</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 16." id="VSP_009838" evidence="85">
<original>DALPSSEDDDDDDDSSSEEKETDNTKPNRMP</original>
<variation>ACPDLQEAKWCSASFHSITPLPFGLGTRLSD</variation>
<location>
<begin position="120"/>
<end position="150"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 14, isoform 15, isoform 18, isoform 19 and isoform 21." id="VSP_002959" evidence="83 84 85 86 87 88 90 91 92 93 94">
<location>
<begin position="148"/>
<end position="149"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 16." id="VSP_009839" evidence="85">
<location>
<begin position="151"/>
<end position="822"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 17 and isoform 18." id="VSP_009840" evidence="92">
<original>TAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMV</original>
<variation>VIMAPVFVGQSTGKETTVSGAQVPVGRLSCPRMGSFLTLQAHTLHLSRDLATSPRTSNRGHKVEVSWEQRAAGMGGAGL</variation>
<location>
<begin position="313"/>
<end position="391"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 19." id="VSP_038471" evidence="86 90">
<original>TAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLE</original>
<variation>HSGINSSDAEVLTLFNVTEAQSGEYVCKVSNYIGEANQSAWLTVTRP</variation>
<location>
<begin position="313"/>
<end position="360"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 17 and isoform 18." id="VSP_009841" evidence="92">
<location>
<begin position="392"/>
<end position="822"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 20." id="VSP_041918" evidence="94">
<location>
<begin position="427"/>
<end position="428"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 5, isoform 8, isoform 9, isoform 12 and isoform 13." id="VSP_002960" evidence="84 89">
<location>
<begin position="428"/>
<end position="429"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13." id="VSP_009842" evidence="89">
<original>CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL</original>
<variation>VWNLKAPLVHTPRPGSQECPGDRGQCDEDSRLWPRTGHSPHRLL</variation>
<location>
<begin position="619"/>
<end position="662"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13." id="VSP_009843" evidence="89">
<location>
<begin position="663"/>
<end position="822"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; unknown pathological significance; dbSNP:rs760884357." id="VAR_074012" evidence="73">
<original>W</original>
<variation>C</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17175750." id="VAR_019290" evidence="82">
<original>R</original>
<variation>S</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism; dbSNP:rs121909640." id="VAR_030968" evidence="45">
<original>G</original>
<variation>S</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs140254426." id="VAR_072993" evidence="72">
<original>G</original>
<variation>R</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs767195580." id="VAR_030969" evidence="48">
<original>N</original>
<variation>K</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030970" evidence="44">
<original>R</original>
<variation>C</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; unknown pathological significance." id="VAR_074013" evidence="73">
<original>S</original>
<variation>C</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_017885" evidence="25">
<original>G</original>
<variation>D</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression; dbSNP:rs727505373." id="VAR_017886" evidence="25 60">
<original>Y</original>
<variation>C</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030971" evidence="48">
<original>C</original>
<variation>F</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs55642501." id="VAR_030972" evidence="32 44">
<original>V</original>
<variation>I</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs747842199." id="VAR_072994" evidence="72">
<original>V</original>
<variation>I</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; some patients also carry GNRHR mutations; dbSNP:rs780765366." id="VAR_069288" evidence="60 69">
<original>N</original>
<variation>S</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs121913473." id="VAR_042201" evidence="51">
<original>S</original>
<variation>L</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs765615419." id="VAR_030973" evidence="32">
<original>D</original>
<variation>A</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs397515481." id="VAR_070851" evidence="70">
<original>L</original>
<variation>S</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with cleft palate, corpus callosum agenesis, unilateral deafness and fusion of fourth and fifth metacarpal bones; dbSNP:rs121909630." id="VAR_017887" evidence="25">
<original>A</original>
<variation>S</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_072995" evidence="72">
<original>V</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with severe ear anomalies." id="VAR_030974" evidence="43">
<original>C</original>
<variation>S</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs869025669." id="VAR_070852" evidence="70">
<original>L</original>
<variation>S</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17851623." id="VAR_030975" evidence="31">
<original>W</original>
<variation>G</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030976" evidence="44">
<original>D</original>
<variation>H</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; some patients also carry KISS1R mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression." id="VAR_069289" evidence="60 69">
<original>Y</original>
<variation>D</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030977" evidence="44">
<original>G</original>
<variation>D</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with or without anosmia; also found in a family member with isolated anosmia; may impair proper folding; dbSNP:rs121909635." id="VAR_030978" evidence="42">
<original>G</original>
<variation>S</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; some patients also carry PROKR2 and GNRH1 mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression." id="VAR_069290" evidence="60 69">
<original>I</original>
<variation>T</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030979" evidence="45">
<original>L</original>
<variation>P</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with or without anosmia; results in Kallmann syndrome in the presence of HS6ST1 mutation TRP-306; reduces receptor affinity for fibroblast growth factor; dbSNP:rs121909645." id="VAR_069291" evidence="60 66 69 72">
<original>R</original>
<variation>Q</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030980" evidence="45 48">
<original>R</original>
<variation>W</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In PS and JWS; dbSNP:rs121909627." id="VAR_004111" evidence="21 76">
<original>P</original>
<variation>R</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung bronchoalveolar carcinoma sample; somatic mutation; dbSNP:rs121913472." id="VAR_042202" evidence="51">
<original>P</original>
<variation>T</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030981" evidence="44">
<original>R</original>
<variation>Q</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030982" evidence="48">
<original>G</original>
<variation>D</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030983" evidence="32 44">
<original>V</original>
<variation>M</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; also found in a family member with isolated anosmia; dbSNP:rs727505369." id="VAR_030984">
<original>E</original>
<variation>G</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_017888" evidence="25">
<original>C</original>
<variation>Y</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030985" evidence="48">
<original>P</original>
<variation>R</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In TRIGNO1; dbSNP:rs121909633." id="VAR_030986" evidence="22">
<original>I</original>
<variation>T</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In OGD; dbSNP:rs121909632." id="VAR_030987" evidence="33 36">
<original>N</original>
<variation>I</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030988" evidence="48">
<original>S</original>
<variation>C</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030989" evidence="44">
<original>Y</original>
<variation>C</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a splice site mutation in NSMF; dbSNP:rs121909638." id="VAR_069954" evidence="69">
<original>L</original>
<variation>S</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030990" evidence="45">
<original>A</original>
<variation>V</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; also found in a family member with isolated anosmia." id="VAR_030991" evidence="44">
<original>S</original>
<variation>C</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a mutation in IL17RD." id="VAR_069955" evidence="69 72">
<original>G</original>
<variation>R</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with or without anosmia; dbSNP:rs121909641." id="VAR_030992" evidence="45">
<original>P</original>
<variation>L</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631." id="VAR_030993" evidence="33">
<original>Y</original>
<variation>C</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="sequence variant" description="In OGD; dbSNP:rs121909634." id="VAR_030994" evidence="33 36">
<original>C</original>
<variation>R</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; some patients also carry GNRHR mutations; dbSNP:rs121909637." id="VAR_069292" evidence="60 69">
<original>R</original>
<variation>L</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in SPRY4; dbSNP:rs397515444." id="VAR_069956" evidence="69">
<original>P</original>
<variation>T</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs869025670." id="VAR_070853" evidence="70">
<original>G</original>
<variation>R</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs749758370." id="VAR_030995" evidence="32">
<original>A</original>
<variation>T</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030996" evidence="44">
<original>I</original>
<variation>V</variation>
<location>
<position position="538"/>
</location>
</feature>
<feature type="sequence variant" description="In ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation." id="VAR_075853" evidence="56 74">
<original>N</original>
<variation>K</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_075854" evidence="74">
<original>V</original>
<variation>M</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with bimanual synkinesis; dbSNP:rs121909629." id="VAR_017889" evidence="25">
<original>V</original>
<variation>M</variation>
<location>
<position position="607"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity." id="VAR_069293" evidence="60 69">
<original>K</original>
<variation>N</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030997" evidence="48">
<original>H</original>
<variation>R</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with severe ear anomalies." id="VAR_030998" evidence="43">
<original>R</original>
<variation>G</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_030999" evidence="43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs398122946." id="VAR_070854" evidence="70">
<original>D</original>
<variation>Y</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs869025671." id="VAR_071460" evidence="71">
<original>R</original>
<variation>T</variation>
<location>
<position position="627"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs869025672." id="VAR_070855" evidence="70">
<original>N</original>
<variation>K</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence variant" description="In ECCL; somatic mutation." id="VAR_075855" evidence="74">
<original>K</original>
<variation>E</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung large cell carcinoma sample; somatic mutation." id="VAR_042203" evidence="51">
<original>V</original>
<variation>L</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with cleft palate." id="VAR_017890" evidence="25">
<original>W</original>
<variation>R</variation>
<location>
<position position="666"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in FLRT3; dbSNP:rs397515446." id="VAR_069957" evidence="69">
<original>E</original>
<variation>K</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_069294" evidence="60">
<original>A</original>
<variation>P</variation>
<location>
<position position="671"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_031000" evidence="48">
<original>S</original>
<variation>F</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs727505376." id="VAR_031001" evidence="34 68">
<original>G</original>
<variation>R</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in DUSP6; dbSNP:rs397515445." id="VAR_069958" evidence="69">
<original>E</original>
<variation>G</variation>
<location>
<position position="692"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_031002" evidence="48">
<original>I</original>
<variation>F</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_031003" evidence="44">
<original>G</original>
<variation>R</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs768957161." id="VAR_031004" evidence="44">
<original>G</original>
<variation>S</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_017891" evidence="25">
<original>M</original>
<variation>R</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; unknown pathological significance." id="VAR_074014" evidence="73">
<original>M</original>
<variation>V</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; associated with K-724; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606805." id="VAR_031005" evidence="42 69">
<original>P</original>
<variation>H</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; dbSNP:rs121909642." id="VAR_031006" evidence="45">
<original>P</original>
<variation>S</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; associated with H-722; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606806." id="VAR_031007" evidence="42 69">
<original>N</original>
<variation>K</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="In HRTFDS; dbSNP:rs398122945." id="VAR_070856" evidence="70">
<original>C</original>
<variation>Y</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2." id="VAR_031008" evidence="28 34">
<original>P</original>
<variation>S</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; the patient also carries a rare variant in FGF8; dbSNP:rs121909644." id="VAR_069959" evidence="69">
<original>D</original>
<variation>Y</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2956723." id="VAR_031009" evidence="44">
<original>L</original>
<variation>V</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; with cleft palate, unilateral absence of nasal cartilage, iris coloboma; dbSNP:rs56234888." id="VAR_017892" evidence="25 48">
<original>P</original>
<variation>S</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In HH2; also found in a family member with isolated anosmia; dbSNP:rs781328162." id="VAR_031010" evidence="45">
<original>V</original>
<variation>I</variation>
<location>
<position position="795"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17182456." id="VAR_019291" evidence="82">
<original>G</original>
<variation>R</variation>
<location>
<position position="818"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17182463." id="VAR_019292" evidence="48 82">
<original>R</original>
<variation>C</variation>
<location>
<position position="822"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="30">
<original>K</original>
<variation>A</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity." evidence="62">
<original>R</original>
<variation>E</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PLCG1.">
<original>R</original>
<variation>V</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="56">
<original>D</original>
<variation>A</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-654." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PLCG1.">
<original>D</original>
<variation>V</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation." evidence="24 26 27 75">
<original>Y</original>
<variation>F</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA35958/AAA35959." ref="8" evidence="95">
<original>S</original>
<variation>C</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA35837." ref="3" evidence="95">
<original>K</original>
<variation>E</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA35835." ref="5" evidence="95">
<original>G</original>
<variation>S</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 16; no nucleotide entry." ref="16" evidence="95">
<original>E</original>
<variation>G</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; BAD96438." ref="12" evidence="95">
<original>S</original>
<variation>F</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA35958/AAA35959." ref="8" evidence="95">
<original>V</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 18; CAA68679." ref="18" evidence="95">
<original>E</original>
<variation>Q</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA75007." ref="1" evidence="95">
<original>P</original>
<variation>L</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; BAD96438." ref="12" evidence="95">
<original>K</original>
<variation>R</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; BAD96438." ref="12" evidence="95">
<original>R</original>
<variation>W</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA36101." ref="4" evidence="95">
<original>G</original>
<variation>R</variation>
<location>
<position position="817"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="63"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="83"/>
<end position="88"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="93"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="97"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="108"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="158"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="174"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="180"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="187"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="199"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="207"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="210"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="214"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="226"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="237"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="273"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="286"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="306"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="320"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="325"/>
<end position="328"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="337"/>
<end position="344"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="349"/>
<end position="358"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="460"/>
<end position="462"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="475"/>
<end position="477"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="478"/>
<end position="486"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="488"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="501"/>
<end position="503"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="508"/>
<end position="516"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="522"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="547"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="553"/>
<end position="555"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="558"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="569"/>
<end position="574"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="579"/>
<end position="583"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="584"/>
<end position="586"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="591"/>
<end position="593"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="597"/>
<end position="616"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="626"/>
<end position="628"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="629"/>
<end position="631"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="637"/>
<end position="639"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="641"/>
<end position="643"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="648"/>
<end position="650"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="653"/>
<end position="655"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="658"/>
<end position="660"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="663"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="669"/>
<end position="674"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="676"/>
<end position="678"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="679"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="706"/>
<end position="714"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="722"/>
<end position="724"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="727"/>
<end position="736"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="741"/>
<end position="743"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="747"/>
<end position="760"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CVS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2CR3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GQI"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3JS2"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KXX"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RWI"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RWL"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UWC"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UWY"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A4C"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AM7"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EW8"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P16092"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255"/>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454568"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10688839"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10830168"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10861678"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11173846"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11353842"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12181353"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12627230"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1379697"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1379698"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15001591"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15034873"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15117958"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15605412"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15625620"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15845591"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16470795"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16481405"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16507368"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1652059"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1656221"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16597617"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16606836"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16757108"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16764984"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16882753"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16946300"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1697263"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17154279"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1722683"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311277"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389761"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17623664"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18441324"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18480409"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224897"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261810"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19665973"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19696444"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19820032"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19966287"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20133753"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20139426"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20422052"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454610"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700882"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21765395"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22927827"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23643382"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23812909"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24888332"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25077900"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26277103"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26942290"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7516330"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7874169"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8622701"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8663044"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9655399"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9716603"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9949182"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source ref="13"/>
</evidence>
<evidence key="83" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1650441"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1652059"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1662973"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1722683"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1846977"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20139426"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2162671"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2167437"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7520751"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000303">
<source ref="12"/>
</evidence>
<evidence key="95" type="ECO:0000305"/>
<sequence length="822" mass="91868" checksum="93A01B5D78C3E72C" modified="1991-05-01" version="3" precursor="true">
MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDD
VQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSD
ALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPS
SGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSIN
HTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKI
GPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLE
ALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKS
IPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVL
GKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK
HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL
VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG
RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD
KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSF
PDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>